The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...

The pharmaceutical giant sold its flex building at the Imperial Center for $41.1 million to New York-based Lightstone Group, ...

The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

BMS is not the only U.S. pharma giant making massive cuts. Last year, Pfizer revealed a similar plan to reduce $1.5 billion ...